Dr. Reddy's Laboratories Limited  

(Public, NSE:DRREDDY)   Watch this stock  
Find more results for DRREDDY
+1.60 (0.06%)
Jul 23 - Close
NSE real-time data - Disclaimer
Currency in INR
Range 2,708.10 - 2,750.00
52 week 2,027.00 - 2,939.40
Open 2,750.00
Vol. 216,649.00
Mkt cap 464.20B
P/E 21.61
Div/yield 18.00/0.66
EPS 126.11
Shares 170.34M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2014
Net profit margin 13.84% 16.28%
Operating margin 16.82% 19.70%
EBITD margin - 19.70%
Return on average assets - 13.76%
Return on average equity - 26.30%
Employees 16,617 -
CDP Score - 76


8-2-337 Road No.3, BANJARA HILLS, Telangana
+91-40-49002900 (Phone)
+91-40-49002999 (Fax)

Website links

External links


Dr. Reddy�s Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active pharmaceutical ingredients (API) business and custom pharmaceutical services (CPS) business, and Proprietary Products segment, which consists of DRL�s new chemical entities (NCEs) business, its Differentiated Formulations business and its dermatology focused specialty business operated through Promius Pharma. On March 27, 2012, DRL launched quetiapine fumarate tablets. On March 2, 2012, it launched ziprasidone hydrochloride capsules. On October 24, 2011, DRL launched olanzapine tablets. On July 25, 2011, it launched fondaparinux sodium injection.

Officers and directors

G. V. Prasad Co-Chairman of the Board, Chief Executive Officer, Managing Director
Age: 53
Satish K. Reddy Co-Chairman of the Board
Age: 46
Sripada Chandrasekhar President, Global Head - Human Resources
Saumen Chakraborty Chief Financial Officer, Global Head - IT & BPE
Age: 52
R. Ananthanarayanan Ph.D. President - Pharmaceutical Services and Active Ingredients
Age: 48
Abhijit Mukherjee Chief Operating Officer
Age: 55
Amit Biswas Executive Vice President - Integrated Product Development
Age: 53
Samiran Das Executive Vice President, Head - FTO and GGPM
Age: 53
Umang Vohra Executive Vice President, Head - North America Generics
Age: 42
Raghav Chari Senior Vice President - Proprietary Products
Age: 43